CAS: 39236-46-9; 1,1'-Methylenebis(3-(3-(Hydroxymethyl)-2,5-Dioxoimidazolidin-4-yl)Urea)

该化合物是一种正丁丁二烯防腐剂,通常用于化妆品和个人护理配方,它作为一种抗微生物剂,有效抑制细菌,酵母和含水产品的霉菌生长.这种环流化合物因其广泛光谱效果,广度pH值的稳定性和与各种化妆品成分的兼容性而具有价值.它缓慢地释放甲丁二烯可确保长期的防腐行动,同时尽量减少潜在的刺激性. 氨丁基尿素特别适合需要温和保存的冲洗产品和配方.作为一种非酚的防腐剂,它为传统寄生虫可能不可取的配方提供了替代物. 它低浓度的功效有助于其在工业中的广泛使用.

结构式图片

欧盟法规

REACH注册欧盟化妆品法规附录五-准用防腐剂清单ECHA物质ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-12221452-B2
    优先权日:2017-10-04
    标题:Synthesis of cantharidin
    发明人:DAVIDSON MATTHEW GENE; EKLOV BRIAN MATTHEW; WUTS PETER; LOERTSCHER BRAD MELVIN; SCHOW STEVEN R
    权利人:VERRICA PHARMACEUTICALS INC
    摘要:The invention provides synthetic methods for the preparation of cantharidin and analogs thereof. In one aspect, the invention provides an improved Diels-Alder cycloaddition to generate a key intermediate en route to cantharidin and analogs thereof. In certain embodiments, the new Diels-Alder reaction involves reacting Compound (2) in the presence of furan, and in the absence of acid or increased pressure, in an aprotic polar solvent with slight warming, to yield Compound (1) in favorable yield and exo-endo ratio. In another aspect, the invention also provides a new Diels-Alder reaction between compounds of Formula (III) and furan to yield compounds of Formula (IV), which can then be transformed into cantharidin or analogs thereof. In yet another aspect, the invention describes a new palladium-mediated carbonylation providing another key intermediate en route to cantharidin and analogs thereof. In addition to synthetic methods, present invention also provides compounds (i.e., intermediates) useful in the synthesis of cantharidin and analogs thereof. Compounds provided herein may have biological activity, and therefore may be used in the treatment of diseases or conditions (e.g., infectious diseases and skin conditions).

    专利号:US-11155562-B2
    优先权日:2014-06-30
    标 题 :Synthesis of halichondrin analogs and uses thereof
    发明人:KISHI YOSHITO; UEDA ATSUSHI; YAMAMOTO AKIHIKO; KATO DAISUKE
    权利人:HARVARD COLLEGE
    摘要:The present invention provides halichondrin analogs, such as compounds of Formula (I). The compounds may bind to microtubule sites, thereby inhibiting microtubule dynamics. Also provided are methods of synthesis, pharmaceutical compositions, kits, methods of treatment, and uses that involve the compounds for treatment of a proliferative disease (e.g., cancer). Compounds of the present invention are particularly useful for the treatment of metastatic breast cancer, non-small cell lung cancer, prostate cancer, and sarcoma. The included methods of synthesis are useful for the preparation of compounds of Formula (I)-(III) along with naturally occurring halicondrins (e.g., halichondrin B & C, norhalichondrin A, B, & C, and homohalichondrin A, B, & C). Also included are methods for interconverting between the halichondrins, norhalichondrins, and homohalichondrins and their unnatural epimers at the C38 ketal stereocenter through the use of an acid-mediated equilibration.

    专利号:US-9982005-B2
    优先权日:2013-04-04
    标 题 :Macrolides and methods of their preparation and use
    发明人:MYERS ANDREW G; SEIPLE IAN BASS; ZHANG ZIYANG
    权利人:HARVARD COLLEGE
    摘要:Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using the inventive macrolides are also provided. A general diastereoselective aldol methodology used in the synthesis of the western half is further provided.

    专利号:US-2023078498-A1
    优先权日:2020-02-07
    标题 :Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis
    发明人:ANDERSON DOUGLAS MATTHEW
    权利人:UNIV ROCHESTER
    摘要:The present disclosure provides proteins, nucleic acids, systems and methods for enhancing the synthesis of a protein.

    专利号:WO-2007094533-A1
    优先权日:2006-02-17
    标题:Composition for inhibiting collagen degradation and promoting collagen synthesis comprising emodin
    发明人:PARK DEOK HOON; LEE JONG SUNG; JUNG EUN SUN; HYUN CHANG GU; HONG SEONG TAEK
    权利人:BIOSPECTRUM INC; PARK DEOK HOON; LEE JONG SUNG; JUNG EUN SUN; HYUN CHANG GU; HONG SEONG TAEK
    摘要:Disclosed is a composition, comprising emodin, for inhibiting collagen degradation and promoting collagen synthesis. The composition stimulates cell regeneration by promoting the synthesis of collagen by normal fibroblasts, alleviates wrinkles, and imparts the skin with elasticity. Also, the composition can be used as a preparation for external use for skin, such as cosmetics.

    专利号:US-2014378538-A1
    优先权日:2011-12-14
    标 题:Methods of responding to a biothreat
    发明人:BANCEL STEPHANE
    权利人:MODERMA THERAPEUTICS INC
    摘要:The present disclosure provides for devices, in particular mobile devices, which may be used in the synthesis of modified nucleic acid molecules, in particular modified mRNA molecules. The device for making the modified nucleosides, modified nucleotides and modified nucleic acids (e.g., mRNA) disclosed herein may be mobile devices comprising at least one sample block for insertion of one or more sample vessels, a device base with electronic control units for the sample block, a voltage supply, and one or more reagent(s) for the synthesis of at least one nucleic acid.
    浙江圣效化学品有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shengxiaochemical.com
    企业联系👤
    📞浙江圣效化学品有限公司 ⚠️参考联系方式
    联系人:内贸 陈峰


    传真:0570-3085678
    邮箱:sx@shengxiaochemical.com
    通信地址: 浙江衢州市荷花东区三十幢C座圣效大楼
    邮编: 324000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江衢州市荷花东区三十幢C座圣效大楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京桑普生物化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sunpubc.com
    电话: 010-63536826👤
    📞北京桑普生物化学技术有限公司 ⚠️参考联系方式

    销售电话:010-63536826
    邮箱:sunpurh@sunpubc.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏省太仓市严林化工厂
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kaijuchem.com
    电话: 0512-53410118 13776174836👤
    📞江苏省太仓市严林化工厂 ⚠️参考联系方式

    销售电话:0512-53410118 13776174836
    邮箱:sales@kaijuchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    安徽东凯生物科技股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.eastskypharm.com
    企业联系电话:0557-5035888👤
    📞安徽东凯生物科技股份有限公司 ⚠️参考联系方式

    电话:0557-5035888
    手机:13357610818
    传真:0557-5035888
    邮箱:yuzhenyun@126.com
    通信地址: 安徽省宿州市经济开发区金江六路6号
    邮编: 235200
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:安徽省宿州市经济开发区金江六路6号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Lafi B, Chaâbane M, Elwej A, Grati M, Jamoussi K, Mnif H, Boudawara T, Ketata Bouaziz H, Zeghal N. Effects of co-exposure to imidacloprid and gibberellic acid on redox status, kidney variables and histopathology in adult rats. Arch Physiol Biochem. 2018 May;124(2):175-184. doi: 10.1080/13813455.2017.1371195. Epub 2017 Sep 6.
    5:1114-1119. doi: 10.1016/j.toxrep.2018.11.003.
    3: Zhang Q, Wang X, Rao Q, Chen S, Song W. Imidacloprid dissipation, metabolism and accumulation in Agaricus bisporus fruits, casing soil and compost and dietary risk assessment. Chemosphere. 2020 Sep;254:126837. doi: 10.1016/j.chemosphere.2020.126837. Epub 2020 Apr 19. 97(9):5459-73. doi: 10.3168/jds.2013-7885. Epub 2014 Jul 3.

    合成参考文献


    参考文献:10.1111/j.1600-0536.2011.01953.x
    摘要:Latorre N, Borrego L, Fernández-Redondo V, García-Bravo B, Giménez-Arnau AM, Sánchez J, Silvestre JF. Patch testing with formaldehyde and formaldehyde-releasers: multicentre study in Spain (2005-2009). Contact Dermatitis. 2011 Nov;65(5):286–92. doi: 10.1111/j.1600-0536.2011.01953.x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知